UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 13, 2013
Verastem, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware |
|
001-35403 |
|
27-3269467 |
|
(State or Other Jurisdiction of Incorporation) |
|
(Commission |
|
(IRS Employer |
|
215 First Street, Suite 440, Cambridge, MA |
|
02142 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (617) 252-9300
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.05 Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.
On June 13, 2013, Verastem, Inc. (the “Company”) granted a one-time waiver of the provision of its Insider Trading Policy that requires executive officers to submit requests to purchase or sell securities of the Company at least two business days in advance of the proposed purchase or sale by approving the request of Robert Forrester, the Company’s President and Chief Operating Officer, to purchase shares of the Company’s common stock, which was submitted by Mr. Forrester and approved by the Company on June 13, 2013.